Xvivo Perfusion AB (publ)
XVIPY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$692.99M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $692.99 Million |
|---|---|
| Enterprise Value | $509.64 Million |
| Earnings per Share | $0.19 |
| Beta | 1.78 |
| Outstanding Shares | 125,997,880 |
Return
| Return on Equity | 5.86% |
|---|---|
| Return on Assets | 5.10% |
| Return on Invested Capital | 5.17% |
Valuation & Multiples
| P/E Ratio | 50.12 |
|---|---|
| PEG | 5.4 |
| Price to Sales | 0.79 |
| Price to Book Ratio | 0.32 |
| Enterprise Value to Revenue | 0.53 |
| Enterprise Value to EBIT | 4.22 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 22, 2026
EPS Estimate
$0.80
Consensus analyst estimateRevenue Estimate
$237.57 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Xvivo Perfusion AB (publ)
210 employees
CEO: Christoffer Rosenblad
Xvivo Perfusion AB (publ) is a specialized medtech company creating advanced technologies for the preservation and perfusion of organs, tissues, and cells, vital for successful transplantation. Founded in 1998 and headquartered in Gothen...